Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Centre Hospitalier Régional d'Orléans
Emory University
University of Maryland, Baltimore
H. Lee Moffitt Cancer Center and Research Institute